Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced that the U.S. Food and Drug Administration approved expanded use of its cystic fibrosis ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE